ASPAC III Acquisition Corp.

ASPC: DEF 14A · proxy statement

A SPAC III Acquisition Corp. has called an Extraordinary General Meeting for October 19, 2026 to vote on extending its business combination deadline by 24 months, from November 12, 2026 to November 12, 2028, to allow time to complete its pending merger with Bioserica International Limited signed May 23, 2025. The extension carries no sponsor support: A SPAC III (Holdings) Corp. does not plan to contribute any funds to the Trust Account, which held only approximately $3.06 million as of September 22, 2026, and the company expects significant redemptions at approximately $10.82 per share. Compounding the risk, Nasdaq notified the company on May 20, 2026 that its stockholders' equity fell below the $2.5 million minimum under Listing Rule 5550(b)(1), with a compliance deadline of November 12, 2026; Nasdaq rules also require a business combination within 36 months of the IPO, and failure could result in delisting or complete liquidation and redemption of public shares.

SEC DEF 14A•27d ago

ASPC: PRE 14A · proxy statement

A SPAC III Acquisition Corp. filed a preliminary proxy statement asking shareholders to amend its charter and extend its business combination deadline by 24 months, from November 12, 2026 to November 12, 2028, to complete its pending merger with Bioserica International Limited under a May 23, 2025 merger agreement. The deal still requires filings with the China Securities Regulatory Commission and the SEC, which the board says leaves too little time before the current deadline. Sponsor A SPAC III (Holdings) Corp. holds 1,785,000 shares, roughly 76.4% of the vote, and has indicated it will vote for the extension, effectively assuring approval. However, the sponsor does not plan to contribute any funds to the trust account to support the extension, and the company explicitly expects significant redemptions at the meeting. The company is also out of compliance with Nasdaq Listing Rule 5550(b)(1), having reported stockholders' equity below the $2,500,000 minimum for the quarter ended March 31, 2026, with a compliance deadline of November 12, 2026. Nasdaq rules further require a business combination within 36 months of the November 2024 IPO, so delisting risk persists even if the two-year extension is approved and succeeds only via a Hearings Panel appeal. If the extension fails and no deal closes by November 12, 2026, the SPAC will redeem 100% of public shares and liquidate, wiping out the sponsor's founder shares purchased for $25,000 in aggregate and its $2,850,000 of private placement units.

SEC PRE 14A•1mo ago

ASPC: 10-Q · periodic report

A SPAC III Acquisition Corp. filed its Q2 2026 10-Q with explicit going-concern doubt: management warns the company faces mandatory liquidation and dissolution if it cannot complete its initial business combination by the November 12, 2026 deadline. The SPAC is also out of compliance with Nasdaq's $2.5 million minimum stockholders' equity rule, reporting just $237,744 in equity. Nasdaq accepted the company's compliance plan on July 17, 2026 and gave it until November 12, 2026 to regain compliance, failing which its securities will face delisting subject to appeal. The company's survival hinges on closing its pending merger with Bioserica International Limited, structured at $217.86 million in all-stock consideration. The trust account holds only $3,032,747 after 5,717,419 public shares were redeemed for $59.5 million in October 2025, leaving just 282,581 public shares outstanding. Cash outside trust fell to $633,724 and the company swung to a Q2 net loss of $15,218 versus year-ago net income of $379,939, as interest income collapsed to $31,977 from $646,975 following the redemptions.

SEC 10-Q•2mo ago

ASPC: 8-K · delisting

A SPAC III Acquisition Corp. (ASPC) received a formal notice from Nasdaq on May 20, 2026, stating it no longer complies with continued listing rules. The exchange cited that the company’s stockholders’ equity reported in its March 31, 2026 10-Q fell below the required minimum of $2.5 million. The company has 45 calendar days to submit a compliance plan to Nasdaq. If accepted, Nasdaq may grant an extension of up to 180 days to regain compliance. There is no assurance that the plan will be accepted or that the company will meet the equity requirement. This delisting warning is a significant bearish signal for the SPAC, highlighting financial distress and the urgent need for a business combination or capital infusion to maintain its listing status.

SEC 8-K•4mo ago